非傳統風險因子與臨床狀況的風險評估 Nontraditional Risk Factors and Clinical Conditions for Risk Assessment of ASCVD
替代風險標記在心血管風險評估中的角色 The Role of Surrogate Risk Markers in Cardiovascular Risk Assessment of ASCVD
針對肥胖、糖尿病及非透析性慢性腎臟病之初級預防藥物治療 Pharmacological Interventions for Obesity, Diabetes Mellitus, and Non-Dialysis Chronic Kidney Disease for Primary Prevention of ASCVD